Sentences with phrase «ovarian health»

When you're proactive with your breast and ovarian health, you're doing your part to reduce your risk of developing breast and ovarian cancer or detect it at an early stage.
As CEO, I focus the majority of my efforts externally to ensure we are continuing to increase awareness, establish meaningful partnerships and influence as many young women in their 20s and 30s to be proactive with their breast and ovarian health.
Once a partnership is established, we work with the brand team to develop comprehensive multi-year programs that are focused on raising funds to reach the most women possible and inspire them to take a proactive approach to their breast and ovarian health.
Encourage the women you love to join you in Being Bright Pink and taking a smart, proactive approach with your breast and ovarian health.
One hour I may be focused on developing a new program with a corporate sponsor, while the next I will have a meeting with three genetic counselors to work on the national expansion of our Breast / Ovarian Health 101 educational workshops.
The organization would be unique and fill a gap in the breast / ovarian health landscape.
Learn more about what you should be doing TODAY to be proactive with your breast and ovarian health by visiting BrightPink.org, and by following Bright Pink on twitter @BeBrightPink and Facebook.
Bright Pink encourages women to «be bright» with their health — to be smart, be positive and be in control of their breast and ovarian health.
In honor of National Breast Cancer Awareness Month, it is our hope that you will join the thousands of young women who are part of the Bright Pink movement and be bright with your breast and ovarian health.
Susie @ SuzLyfe recently posted... Join me at Bright Pink Fit Fest for Breast and Ovarian Health!
I am also interested in how you think green tea as an anti oxidant might impact ovarian health?
In partnership with Bright Pink, Pure Barre was able to successfully contribute to the worthwhile mission of encouraging young women to be proactive about their breast and ovarian health.

Not exact matches

The company will now be able to sell health risk reports on three variants found on the BRCA1 and BRCA2 genes, which are linked with a higher risk of breast, ovarian, and prostate cancer.
They have been shown to protect against macular degeneration, ovarian cancer, colon cancer and promote gastrointestinal health amoung other things.
Green smoothies are goitrogenic and cause hypothyroidism, almond milk and other non-dairy milks can make you psychotic, and kombucha and green tea are loaded with fluoride which causes all kinds of health problems from migraine headaches to arthritis to ovarian cysts.
As well as bonding with the baby when sharing the breastfeeding, lesbian parents report enjoying the effects of the relaxation hormones released when lactating (resulting in lower stress levels in the parent and baby), the flexibility of having two nursing parents when one needs to absent herself occasionally or when returning to work, and the health benefits of breastfeeding such as lower rates of breast cancer, ovarian cancer and Type II diabetes (8), (9).
Smoking, hypothyroidism, Polycystic Ovarian Syndrome, previous breast surgery, or other medical health issues can make it difficult or impossible for mom to breastfeed on demand and can inhibit milk supply.
Additionally, the U.S. Department of Health and Human Services finds that women who breastfeed their babies probably lower their risk for developing breast cancer, type 2 diabetes, ovarian cancer, postpartum depression, and rheumatoid arthritis.
Type 2 diabetes, certain types of breast cancer, and ovarian cancer are just a few health risks that are decreased by breastfeeding.
Breastfeeding is also associated with maternal health outcomes.5 Shorter duration of lactation is associated with increased maternal breast cancer, 6 ovarian cancer, 7,8 hypertension, 9 — 11 type 2 diabetes mellitus, 9,12 and myocardial infarction (MI).9, 13 We estimate the burden of maternal disease that might be averted if more mothers were able to adhere to infant feeding recommendations, assuming a causal association between breastfeeding and maternal health.
To obtain indirect costs for breast and ovarian cancer, we applied the ratio from the National Institutes of Health of indirect to direct costs of cancer of 0.229.39
Extended breastfeeding even has health benefits for me, including reduced risk of breast, ovarian, uterine, and endometrial cancers.
Today I would add that breastfeeding reduces ovarian and cervical cancer, juvenile rheumatoid arthritis, bacterial and viral infections of all types and increases visual acuity, optimal neurological and social and oral development, as well as saves money for health care providers and families.
For the mother who breastfeeds, there may be health benefits including reduced risk of ovarian and breast cancer, heart disease, and osteoporosis.
Enabling women to breastfeed is also a public health priority because, on a population level, interruption of lactation is associated with adverse health outcomes for the woman and her child, including higher maternal risks of breast cancer, ovarian cancer, diabetes, hypertension, and heart disease, and greater infant risks of infectious disease, sudden infant death syndrome, and metabolic disease (2, 4).
Also, breastfeeding helps improve maternal health by reducing the risk of cardiovascular diseases, postpartum depression, ovarian cancer and breast cancer [9].
Benefits of extended breastfeeding for mom include reduced risks of breast cancer, ovarian cancer, high blood pressure, heart disease, diabetes, and rheumatoid arthritis, as well as improved health.
Important health benefits of breastfeeding and lactation are also described for mothers.83 The benefits include decreased postpartum bleeding and more rapid uterine involution attributable to increased concentrations of oxytocin, 84 decreased menstrual blood loss and increased child spacing attributable to lactational amenorrhea, 85 earlier return to prepregnancy weight, 86 decreased risk of breast cancer, 87 — 92 decreased risk of ovarian cancer, 93 and possibly decreased risk of hip fractures and osteoporosis in the postmenopausal period.94 — 96
Our friends at Bright Pink have made it their mission to spread knowledge about breast and ovarian cancer, empowering women to be proactive about their health.
Breastfeeding also enhances the bond between mother and child, is cost - free and convenient, and can reduce the risk of some health problems in women like ovarian cancer.
Scientists at Lawson Health Research Institute have uncovered an important new target for ovarian cancer therapy.
According to a 2014 review of cancer medicines from the World Health Organization, EOC is the most common type of ovarian cancer and has a 5 - year survival rate of approximately 40 %.
To identify the relevant mutations the scientists analyzed the blood samples of 1,858 men from three independent cohorts in Europe and North America: the Swiss arm of the European Randomized Study for Prostate Cancer Screening, the large American Screening trial, Prostate, Lung, Colorectal, and Ovarian (PLCO), Princess Margaret Cancer Centre (University Health Network) and Mount Sinai Hospital (Sinai Health System) in Toronto.
Funding for the study was provided by the National Institutes of Health (P50 CA083638, R21 CA156224, 5P30 CA016520 - 36), the Marcus Foundation, the Ovarian Cancer Immunotherapy Initiative, the Ludwig Institute for Cancer Research at the University of Lausanne, and the Ovacure Foundation.
The role of weight in ovarian - cancer risk emerges from an analysis of data on some 68,000 women participating in one of three major ongoing investigations: the New York (City) University Women's Health Study, the Northern Sweden Health and Disease Study in Umea, and the Diet in the Etiology of Breast Cancer Study in Milan, Italy.
Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer.
The results come from analysis of one arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), the world's largest ovarian cancer screening trial, led by UCL and funded by the Medical Research Council, Cancer Research UK, Department of Health and The Eve Ovarian Cancer Screening (UKCTOCS), the world's largest ovarian cancer screening trial, led by UCL and funded by the Medical Research Council, Cancer Research UK, Department of Health and The Eve ovarian cancer screening trial, led by UCL and funded by the Medical Research Council, Cancer Research UK, Department of Health and The Eve Appeal.
Sood and colleagues looked at samples from 80 cases of human ovarian cancer grouped according to patient stress using the National Institutes of Health's Center for Epidemiological Studies Depression scale as a surrogate marker.
«What we did in this paper is engineer our sensor to be about 15 times better than a previous version, and then compared it against a blood biomarker in a mouse model of ovarian cancer to show that we could beat it,» says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and the senior author of the study.
Rather than «making an 80 - year - old grandma pregnant,» Tilly says, his research aims to create an animal model for studying the health benefits and risks of prolonged ovarian function.
In this study, researchers used blood samples collected several years before breast cancer development from two large UK cohorts of women — the MRC National Survey of Health and Development and the UK Collaborative Trial of Ovarian Cancer Screening.
This project, part of the U.S. National Institutes of Health's The Cancer Genome Atlas (TCGA), focused on high - grade serous ovarian adenocarcinoma, an aggressive disease that accounts for about 70 % of the 14,000 deaths from ovarian cancer in the United States each year.
The National Institutes of Health says that mutations in the BRCA1 and BRCA2 genes tend to increase ovarian cancer risk, but the presence of such a mutation does not guarantee that a cancer will form.
Tags: AACR 2017, aacr 2018, Breast Cancer, Christopher J Kemp, Clinical Research, Colorectal Cancer, Eddie Mendez, genomics, head neck cancers, Human Biology, Ovarian Cancer, Pancreatic Cancer, precision medicine, Public Health Sciences, solid tumors, uterine cancer, Vijayakrishna Gadi
Funding: National Institutes of Health grants CA190176, CA123088, CA099985, CA193136, CA152470, CA171306, 5P30 CA46592; Rivkin Ovarian Cancer Center, Ovarian Cancer Research Fund, Barbara and Don Leclair
She explored these policy interests at the Ovarian Cancer National Alliance, where she disseminated health coverage data to state policymakers and advocated for the development of improved, equitable healthcare systems for women.
The study, entitled «Prognostic factors modifying the treatment - free interval in recurrent ovarian cancer,» was supported in part by Roswell Park Comprehensive Cancer Center, a grant from the Roswell Park Alliance Foundation Institute and National Institutes of Health grants P50CA159981 (SPORE award to Roswell Park and the University of Pittsburgh Cancer Institute), P30CA016056, K01LM012100, R01HG007377 and T32CA108456.
They also found that it wasn't just exposure, but increasing exposure over time that was also connected to problems with ovarian function, another potential consequence of the chemicals on reproductive health.
According to health experts, there is a strong link between consumption of sulfur compounds and a lower rate of ovarian, laryngeal, esophageal, and colorectal cancers.
«This is a new potential treatment paradigm for stage 3 and 4 ovarian cancer,» added Dr. Jennifer Obel, an attending physician at Northshore University Health System and moderator of a Sunday news conference at which these results were presented.
a b c d e f g h i j k l m n o p q r s t u v w x y z